Clobazam as an add‐on in the management of refractory epilepsy
References
Additional references
Cockerell OC, Johnson L, Sander JWAS, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346:140‐4.
Gastaut H, Low M. Antiepileptic properties of clobazam, a 1,5 benzodiazepine in man. Epilepsia 1979;20:437‐46.
Guberman A. Monotherapy or polytherapy for epilepsy. Canadian Journal of Neurological Science 1998;25:3‐8.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports or randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1‐12.
Kruse HJ. Psychopharmacology of clobazam with special reference to its anticonvulsant activity. Clobazam. London: Royal Society of Medicine Services Limited, 1985; Vol. 74.
Kwan P, Brodie MJ. Early identification of refractory epilepsy. New England Journal of Medicine 2000;342(5):314‐9.
Shenoy AK, Miyahara JT, Swinyard EA, Kupferberg HJ. Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital and valproate in mice and rats. Epilepsia 1982;23(4):399‐408.
Theis JGW, Koren G, Daneman R, Sherwin AL, Menzano E, Cortex M, et al. Interactions of clobazam with conventional antiepileptics in children. Journal of Child Neurology 1997;12:208‐13.
